ArticleFrontiers in nutrition2025
Longitudinal assessment of oral intake adequacy and nutrition-impacted symptoms in patients undergoing allogeneic hematopoietic stem cell transplantation.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: This study aims to longitudinally assess the adequacy of oral intake and burden of nutrition-impacted symptoms (NIS) and identify modifiable factors associated with oral intake adequacy in allogeneic hematopoietic stem cell transplantation patients. Methods: A single-center prospective study enrolled allogeneic hematopoietic stem cell transplantation patients from May 19, 2022 to February 8, 2023. We evaluate the adequacy of oral intake and nutrition-impacted symptoms in the peritransplantation period. Generalized estimating equations were adopted to evaluate associated factors of the adequacy of oral energy and protein intake. Results: A total of 63 allogeneic hematopoietic stem cell transplantation patients were enrolled in the study, with 439 records. The adequacy of oral energy/protein intake showed a trend of decreasing first and then increasing, and 57.1-95.2% of the patients suffered from at least one nutritionally impacted symptom in the peritransplantation period. Generalized estimating equations indicated that the presence of nutrition impacted symptoms was a risk factor significantly associated with the adequacy of oral energy intake <50%, while the use of oral nutrition supplements was a protective factor. There were similar associations between the adequacy of oral protein intake <50% and the above two factors. Conclusion: Insufficient oral energy and protein intake and the burden of nutrition impacted symptoms in peritransplantation patients are common, and further attention and intervention on these issues are needed. Oral nutrition supplements are a potential approach to increase oral intake and nutritional status in allogeneic hematopoietic stem cell transplantation patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.